Chris Wood

Robert Ross

Chris Wood is Mauldin Economics’ chief investment officer for healthcare and biotech, as well as the chief investment officer at RiskHedge, a professional investment research firm focused on understanding and profiting from disruption.

A 16-year market veteran, he’s one of America’s most respected analysts and has the track record to prove it. His unique ability to consistently pinpoint stocks that double and triple has intrigued thousands of readers.